Champion for Patient & Consumer Safety and Efficacy | Catalysts for Systems and Wellness | Quality across Product & Engagement | Sustainable Solutions in and with AI, Digital, Drugs, and Media
I've refreshed Enthereal's pitch. I've found it more challenging to "find my people" here on LinkedIn than I anticipated, but that's okay because it takes the time it takes. However, I can't wait any longer to hold back on this, because this invention could have been preventing the current supply chain fiascos going on with ADHD medications, if I had received funding from the handful of VCs I pitched, two years ago. We're pinpointed a real need with the ADHD meds shortages roiling supply chains across the country, really. Even the FDA is being clear that it knows there is not enough amphetamine, methamphetamine, dopamine, and ketamine in the pharmaceutical supply chain channels. How ironic that people can't get medicines from their pharmacist, but they can get it from illegal sources where the quality and identity of substances is uncertain. We need to create more regulated markets that allow for a broad swath of entrepreneurs to participate who have passions for quality, safety, and creating products that people demand. I've held back for too long. The Enthereal tech stake is a technology for an existing market with a new twist on a more and more used approach. The time has come for it to make an even bigger impact. I discovered, invented enabling modifications, and patented a more efficient process to make ADHD medicines from the commodity amino acid L-Phenylalanine. This is a world-changing discovery and its application is only the first step in the realization of a more resilient way our essential medicines will be made, more and more. We're here at the beginning, standing on the shoulders of giants, and we're inviting you all to be part of our growth and development from the very beginning. Tell a friend. They'll be glad you did. More numbers upon request. Turn-key business, once we validate several high-risk, high-reward hypotheses. We're focused on essential medicines and that includes amphetamine, ketamine, methamphetamine, dopamine, epinephrine, norepinephrine; the patented technology also produces MDMA, mescaline, DOM, and others and related precursors.
Current Shortages from the FDA Website (from Dec 2023) "Current and Resolved Drug Shortages and Discontinuations Reported to FDA" • December 20, 2023: "Amphetamine, misc salts; dextroamphetamine (currently in shortage)" "Ketamine Hydrochloride Injection (Currently in Shortage)" • December 19, 2023: "Dopamine Hydrochloride Injection (Currently in Shortage)" "Methamphetamine Hydrochloride Tablet (Currently in Shortage)" These are not new problems - Adderall's been in shortage since October 2022! With no end in sight. If Enthereal has been funded when we originally pitched a handful of VCs in 2021, we'd have a flexible production capability that could be that much closer to solving these shortages - with our single platform From https://lnkd.in/e9UK_f8
